financetom
Business
financetom
/
Business
/
ASGN's ECS Gets $96 Million 4-Year Department of Health and Human Services Contract
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ASGN's ECS Gets $96 Million 4-Year Department of Health and Human Services Contract
Dec 10, 2024 8:39 AM

11:15 AM EST, 12/10/2024 (MT Newswires) -- ASGN's ( ASGN ) ECS unit said Tuesday that it became the prime contractor for a $96 million four-year contract from the Department of Health and Human Services' Advanced Research Projects Agency for Health.

ECS will provide ARPA-H's mission offices of health science futures and scalable solutions with program management and financial management support on biotech, neuroscience and regenerative medicine projects.

Price: 90.27, Change: +0.14, Percent Change: +0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom Insider Sold Shares Worth $288,000, According to a Recent SEC Filing
Broadcom Insider Sold Shares Worth $288,000, According to a Recent SEC Filing
Sep 17, 2025
05:13 PM EDT, 09/17/2025 (MT Newswires) -- Justine Page, Director, on September 15, 2025, sold 800 shares in Broadcom ( AVGO ) for $288,000. Following the Form 4 filing with the SEC, Page has control over a total of 22,982 common shares of the company, with 22,982 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730168/000135956125000005/xslF345X05/wk-form4_1758143268.xml ...
Biogen Gets EU Approval for Postpartum Depression Treatment
Biogen Gets EU Approval for Postpartum Depression Treatment
Sep 17, 2025
05:14 PM EDT, 09/17/2025 (MT Newswires) -- Biogen (BIIB) said late Wednesday the European Commission granted marketing authorization for Zurzuvae, its once-daily oral therapy for postpartum depression in adults following childbirth. The approval was based on results from the late-stage Skylark study, which showed Zurzuvae met its primary endpoint by significantly reducing depression scores on the Hamilton Rating Scale by...
Market Chatter: Blackstone, TPG Restart Discussions to Acquire Hologic
Market Chatter: Blackstone, TPG Restart Discussions to Acquire Hologic
Sep 17, 2025
05:13 PM EDT, 09/17/2025 (MT Newswires) -- Blackstone (BX) and TPG (TPG) have restarted discussions on acquiring medical device maker Hologic ( HOLX ) , Bloomberg reported Wednesday, citing sources with knowledge of the matter. The investment firms have recently reconnected with Hologic's ( HOLX ) board to discuss a potential takeover and are currently conducting due diligence, the media...
Ciena Insider Sold Shares Worth $330,000, According to a Recent SEC Filing
Ciena Insider Sold Shares Worth $330,000, According to a Recent SEC Filing
Sep 17, 2025
05:13 PM EDT, 09/17/2025 (MT Newswires) -- David M Rothenstein, Senior Vice President and Chief Strategy Officer, on September 15, 2025, sold 2,500 shares in Ciena (CIEN) for $330,000. Following the Form 4 filing with the SEC, Rothenstein has control over a total of 190,628 common shares of the company, with 190,628 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/936395/000144415725000021/xslF345X05/edgardoc.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved